The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The significance of insulin receptor expression to predict the resistance to VEGFR-TKIs and induce PD-L1 expression in advanced clear cell renal cell carcinoma.
 
Masayuki Takahashi
Honoraria - Bayer; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Ono Pharmaceutical
 
Kei Daizumoto
No Relationships to Disclose
 
Tomoya Fukawa
No Relationships to Disclose
 
Yayoi Fukuhara
No Relationships to Disclose
 
Keisuke Ozaki
No Relationships to Disclose
 
Megumi Tsuda
No Relationships to Disclose
 
Yoshito Kusuhara
No Relationships to Disclose
 
Hidehisa Mori
No Relationships to Disclose
 
Yasuyo Yamamoto
No Relationships to Disclose
 
Kunihisa Yamaguchi
No Relationships to Disclose
 
Tomoharu Fukumori
No Relationships to Disclose
 
Hiroomi Kanayama
Honoraria - Bayer; Novartis; Ono Pharmaceutical; Pfizer